Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sherry R. Pierce"'
Autor:
Danielle Hammond, Sanam Loghavi, Sa A. Wang, Marina Y. Konopleva, Tapan M. Kadia, Naval G. Daver, Maro Ohanian, Ghayas C. Issa, Yesid Alvarado, Nicholas J. Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A. Lachowiez, Abhishek Maiti, Guillermo Garcia-Manero, Elias J. Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R. Pierce, Hagop M. Kantarjian, Courtney D. DiNardo
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/b7c6599d1ff945fc8f42960c8b15f42e
Autor:
Alexandre Bazinet, Tapan M. Kadia, Nicholas J. Short, Gautam Borthakur, Sa A. Wang, Wei Wang, Sanam Loghavi, Jeffrey L Jorgensen, Keyur P Patel, Courtney D DiNardo, Naval G. Daver, Yesid Alvarado, Fadi G. Haddad, Sherry R Pierce, Graciela M Nogueras Gonzalez, Abhishek Maiti, Koji Sasaki, Musa Yilmaz, Philip A Thompson, William G. Wierda, Guillermo Garcia-Manero, Michael Andreeff, Elias J. Jabbour, Marina Y. Konopleva, Xuelin Huang, Hagop M Kantarjian, Farhad Ravandi
Publikováno v:
Blood Advances.
Acute myeloid leukemia (AML) can be treated with either high or low-intensity regimens. Highly sensitive assays for measurable residual disease (MRD) now allow for a more precise assessment of response quality. We hypothesized that treatment intensit
Autor:
Hussein A, Abbas, Hanxiao, Sun, Sherry R, Pierce, Rashmi, Kanagal-Shamanna, Ziyi, Li, Musa, Yilmaz, Gautam, Borthakur, Adam J, DiPippo, Elias J, Jabbour, Marina Y, Konopleva, Nicholas J, Short, Courtney D, DiNardo, Naval G, Daver, Farhad, Ravandi, Tapan M, Kadia
Publikováno v:
Blood advances.
Autor:
Aziz Nazha, Hagop M. Kantarjian, Elias Jabbour, Courtney D. DiNardo, Gautam Borthakur, Naval G. Daver, Stefan H. Faderl, Jing Ning, Wei Qiao, Farhad Ravandi, Tapan M. Kadia, Sherry R. Pierce, Jorge E. Cortes, Guillermo Garcia-Manero
Publikováno v:
Blood. 122:2788-2788
Background In 2001, the World Health Organization modified the French-American-British (FAB) classification for myelodysplastic syndrome (MDS) by folding the refractory anemia with excess blasts in transformation (RAEB-t) category into acute myeloid
Autor:
Shilpan S. Shah, Hagop M Kantarjian, Farhad Ravandi, Susan O'Brien, Guillermo Garcia-Manero, Michael Andreeff, Marina Konopleva, Elias Jabbour, Sherry R. Pierce, Gautam Borthakur, Jorge E. Cortes
Publikováno v:
Blood. 122:2654-2654
Background Patients with acute myeloid leukemia (AML) who achieve complete remission (CR) after frontline therapy have better outcomes in terms of relapse-free survival and overall survival than those who fail to achieve CR. Patients that achieve com
Autor:
Rozovski Uri, Maro Ohanian, Farhad Ravandi, Guillermo Garcia-Manero, Stefan H. Faderl, Jorge E. Cortes, Sherry R. Pierce, Kantarjian Hagop, Zeev Estrov
Publikováno v:
Blood. 122:3883-3883
It is thought that unlike acute lymphoblastic leukemia, adult acute myeloid leukemia (AML) rarely disseminates to the central nervous system (CNS). Therefore, routine lumbar puncture (LP) is rarely performed in patients with newly diagnosed AML, and
Autor:
Farhad Ravandi, Megan Othus, Stefan H. Faderl, Derek L. Stirewalt, Sherry R. Pierce, Gautam Borthakur, John Godwin, Jeanne E. Anderson, Stephen Petersdorf, Jorge E. Cortes, Fabiana Ostronoff, Era Pogosova-Agadijanyan, Frederick R. Appelbaum, Hagop M. Kantarjian, Elihu H. Estey
Publikováno v:
Blood. 122:2686-2686
Background The value of “high dose” cytarabine (HDAC) during initial induction therapy for patients with newly diagnosed AML remains controversial with some prior reports suggesting improved relapse-free survival (RFS) but not complete remission